Trademarkia Logo

Australia

AU$
akaftreo, AKAFTREO
Cancelled: Cancelled at the request of IB

Last updated on 23 Nov 2022

Owner Info

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

1982364 filed on 14 Nov 2018

Correspondent

Timothy H. Hiebert

Womble Bond Dickinson (US) LLP,

470 Atlantic Avenue, Suite 600,

UNITED STATES OF AMERICA

akaftreo, AKAFTREO

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cystic fibrosis.

Mark Details


Serial Number

1982364

Registered On

14 Nov 2018

Renewal On

NA

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

16 May 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
23rd Nov 2022Status change to Voided
30th Jul 2020Amendment to International Registration Contact Requested
25th Jun 2019International Registration in Australia Protected correspondence sent
24th Jun 2019Status change to Registered/Protected
24th Jun 2019IP Right Registration Published
16th Apr 2019Application Accepted correspondence sent
16th Apr 2019IP Right Acceptance Published
16th Apr 2019IP Right has been Examined
16th Apr 2019Status change to Accepted
21st Feb 2019Indexing details updated